Delivery of bioactive agents from recombinant polymers

被引:31
作者
Dandu, Ramesh [1 ]
Ghandehari, Hamidreza [1 ]
机构
[1] Univ Maryland, Sch Pharm, Ctr Nanomed & Cellular Delivery, Dept Pharmaceut Sci, Baltimore, MD 21201 USA
基金
美国国家卫生研究院;
关键词
genetically engineered polymers; drug delivery; gene delivery; tissue engineering;
D O I
10.1016/j.progpolymsci.2007.05.015
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Since their conception, genetically engineered protein-based polymers have stimulated researchers with the novelty of the synthetic strategy that allows unprecedented control over the sequence and macromolecular architecture of the produced biomaterials. Recombinant polymer synthesis allows the systematic correlation of polymer structure with function, thus enabling customization to suit specific delivery needs. Over the past few years we have focused on the design and development of recombinant polymers for localized delivery of bioactive agents. In this article progress made in the application of silk-elastinlike protein polymers (SELPs) as matrices for the delivery of drugs, genes, viral vectors, and recently tissue engineering is reviewed. In addition the conceptual design, biosynthesis, characterization and biological evaluation of a new polymer consisting of lysine residues to condense plasmid DNA, histidine residues to allow endosomal escape, and the basic fibroblast growth factor as a targeting moiety, for systemic gene delivery applications is discussed. Finally comments are made about the prospects and challenges in the development of recombinant polymers for controlled delivery of bioactive agents. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1008 / 1030
页数:23
相关论文
共 71 条
[1]   Chondrogenic differentiation of mesenchymal stem cells from bone marrow: Differentiation-dependent gene expression of matrix components [J].
Barry, F ;
Boynton, RE ;
Liu, BS ;
Murphy, JM .
EXPERIMENTAL CELL RESEARCH, 2001, 268 (02) :189-200
[2]  
Behr JP, 1997, CHIMIA, V51, P34
[3]   Chondrocytic differentiation of human adipose-derived adult stem cells in elastin-like polypeptide [J].
Betre, H ;
Ong, SR ;
Guilak, F ;
Chilkoti, A ;
Fermor, B ;
Setton, LA .
BIOMATERIALS, 2006, 27 (01) :91-99
[4]   Characterization of a genetically engineered elastin-like polypeptide for cartilaginous tissue repair [J].
Betre, H ;
Setton, LA ;
Meyer, DE ;
Chilkoti, A .
BIOMACROMOLECULES, 2002, 3 (05) :910-916
[5]   A thermally responsive biopolymer for intra-articular drug delivery [J].
Betre, Helawe ;
Liu, Wenge ;
Zalutsky, Michael R. ;
Chilkoti, Ashutosh ;
Kraus, Virginia B. ;
Setton, Lori A. .
JOURNAL OF CONTROLLED RELEASE, 2006, 115 (02) :175-182
[6]  
Blanckaert VD, 1998, CLIN CANCER RES, V4, P2939
[7]   In vitro and in vivo gene transfer with poly(amino acid) vesicles [J].
Brown, MD ;
Gray, AI ;
Tetley, L ;
Santovena, A ;
Rene, J ;
Schätzlein, AG ;
Uchegbu, IF .
JOURNAL OF CONTROLLED RELEASE, 2003, 93 (02) :193-211
[8]   Hydrogel properties influence ECM production by chondrocytes photoencapsulated in poly(ethylene glycol) hydrogels [J].
Bryant, SJ ;
Anseth, KS .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 2002, 59 (01) :63-72
[9]   CORRELATION BETWEEN MESH SIZE AND EQUILIBRIUM DEGREE OF SWELLING OF POLYMERIC NETWORKS [J].
CANAL, T ;
PEPPAS, NA .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1989, 23 (10) :1183-1193
[10]   GENETIC-ENGINEERING OF STRUCTURAL PROTEIN POLYMERS [J].
CAPPELLO, J ;
CRISSMAN, J ;
DORMAN, M ;
MIKOLAJCZAK, M ;
TEXTOR, G ;
MARQUET, M ;
FERRARI, F .
BIOTECHNOLOGY PROGRESS, 1990, 6 (03) :198-202